Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers.
Rubinson DA, Tanaka N, Fece de la Cruz F, Kapner KS, Rosenthal MH, Norden BL, Barnes H, Ehnstrom S, Morales-Giron AA, Brais LK, Lemke CT, Aguirre AJ, Corcoran RB
Cancer Discov. 2024 Jan 18. doi: 10.1158/2159-8290.CD-23-1138.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.